New England Journal of MedicineOriginal article
Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty
Data ReadoutRivaroxabanAspirinNeutral
AI Analysis
Summary
New England Journal of Medicine publishes research comparing rivaroxaban followed by aspirin versus aspirin alone for thromboembolism prevention after total hip or knee arthroplasty. Insufficient detail provided to assess clinical significance or outcomes.
Clinical Trial Data
Importance:3/10
Sentiment:
0.00
clinical_trialNew England Journal of Medicineorthopedic_surgeryanticoagulation
Related Companies
Read the original article
Published by New England Journal of Medicine on July 12, 2026 9:15 AM
